Adage Capital Partners
PCRX icon

Adage Capital Partners’s Pacira BioSciences PCRX Stock Holding History

Adage Capital Partners’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-409,997
Closed -$10.6M – 983
2025
Q3 		$10.6M Buy
+409,997
New +$10.1M 0.02% 616
2016
Q2 		– Sell
-400,000
Closed -$21.2M – 713
2016
Q1 		$21.2M Hold
400,000
– – 0.06% 356
2015
Q4 		$30.7M Buy
+400,000
New +$22.6M 0.08% 281

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners's PCRX Position: Q4 2025 in Review

Adage Capital Partners sold out of Pacira BioSciences (PCRX) in Q4 2025, closing a stake of 409,997 shares — an estimated $10.6M sold.

Adage Capital Partners first reported a position in PCRX in Q4 2015 and held it in 3 quarters. The position peaked at $30.7M in Q4 2015. 260 funds tracked by Wall St. Rank hold PCRX as of Q4 2025.

  • Adage Capital Partners reported no remaining Pacira BioSciences position as of Q4 2025 after selling out during the quarter.
  • Adage Capital Partners sold 409,997 Pacira BioSciences shares in Q4 2025, an estimated $10.6M.
  • Adage Capital Partners first reported a position in Pacira BioSciences in Q4 2015 and held it in 3 quarters.
  • Adage Capital Partners's Pacira BioSciences position peaked at $30.7M in Q4 2015.
  • 260 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2025.

Based on Adage Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.